English
Spanish
Blog
ONCOLOGY: Hematological Malignancies
Chronic Myeloid Leukemia (RT-PCR) – Currently approved only for NJ BCR-ABL assay is an in vitro nucleic acid amplification test for the quantitation of BCR-ABL1 and ABL1 transcripts in total RNA from whole blood of diagnosed t(9;22) positive...
Read More ›
HEREDITARY (GENETIC) SCREENING
Hemachromatosis (HFE Gene Testing) – Currently approved only for NJ HFE Hemochromatosis gene (HFE) testing is a blood test used to check for hereditary hemochromatosis, an inherited disorder that causes the body to absorb too much iron. The iron...
Read More ›
Fragile X (FXS Gene Testing)
Currently approved only for NJ Fragile X is a triplet CGG repeat primed PCR assay followed by fragment size analysis by capillary electrophoresis (CE). Methylation analysis is used to distinguish between premutation and full mutation alleles....
Read More ›
SMN1 testing (For Spinal Muscular Atrophy)
Currently approved only for NJ SMN1 is a multiplex PCR assay used to amplify exon 7 of the SMN1 gene along with an endogenous control gene followed by peak resolution by capillary electrophoresis. SMA is an autosomal recessive neuromuscular disease...
Read More ›
BRCA gene Screening (for Breast Cancer)
Currently approved only for NJ, submitted for NY approval Analysis of BRCA1 and BRCA2 genes is a crucial tool in breast and ovarian cancer screening. Lincoln Labs BRCA Analysis offers: Turnaround time of 10-15 days Preauthorization required....
Read More ›
BreathID for H. Pylori
Currently approved only for NJ and NY The Exalenz BreathID® lab assay is indicated for use as an aid in the initial diagnosis and post treatment monitoring of H. pylori infection in adult patients. It is intended for use to non-invasively measure...
Read More ›